Matthew Boland Yurgelun MD

Clinical Fellow in Medicine, Beth Israel Deaconess Medical Center

450 Brookline AveBoston, MA 02215
Phone+1 617-632-6835

Dr. Yurgelun is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Yurgelun's full profile Already have an account?

Education & Training

Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2006 - 2009
Columbia University Vagelos College of Physicians and SurgeonsClass of 2006

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2022 - Present
MA State Medical License 2009 - 2028
ME State Medical License 2023 - 2028
NH State Medical License 2022 - 2028
RI State Medical License 2022 - 2028
CT State Medical License 2022 - 2027
VT State Medical License 2022 - 2026
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2013, 2015, 2017
CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2013, 2015, 2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015, 2017

Clinical Trials

Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy Start of enrollment: 2017 Feb 24
ACTIVE_NOT_RECRUITING

Publications & Presentations

PubMed

Genomic characterization of therapy-associated polyposis reveals an alkylating mutational signature from prior treatment.
Yashika Parashar, Zsofia Sztupinszki, Aurel György Prósz, Xiaolu Wang, Pratyusha Bala
The Journal of Clinical Investigation. 2026-08-04
Beyond the Locus: Learning Tumor Microsatellite Instability Status From Genome and Transcriptome Sequencing.
Joshua D Cohen, Matthew B Yurgelun
JCO Clinical Cancer Informatics. 2026-07-27
Impact of vitamin D on the colon cancer immune microenvironment: results of a randomized clinical trial of preoperative vitamin D supplementation in patients with stag...
Andressa Dias Costa, Suryun Kim, Sung Chul Hong, Chen Yuan, Xinran Qi
Cancer Discovery. 2026-07-08

Journal Articles

Germline Cancer Susceptibility Gene Variants, Somatic Second Hits, and Survival Outcomes in Patients with Resected Pancreatic Cancer
Richard F Dunne, Leona A Doyle, William C Hahn, Jason L Hornick, Andrea J Bullock, Sapna Syngal, Albert C Koong, Natalia Khalaf, Brian M Wolpin, Douglas A Rubinson, Da..., Nature
Validation of a Targeted Next-Generation Sequencing Approach to Detect Mismatch Repair Deficiency in Colorectal Adenocarcinoma
Lynette M Sholl, Amitabh Srivastava, Neal I Lindeman, Matthew B Yurgelun, Fei Dong, Nature

Lectures

Implementation of systematic genetic counseling (GC) and multigene germline testing (MGT) for pancreatic cancer (PC) patients (pts).
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The GENetic Education, Risk Assessment and TEsting (GENERATE) study.
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
Improving cascade genetic testing for families with inherited pancreatic cancer (PDAC) risk: The genetic education, risk assessment and testing (GENERATE) study.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

More Than 145 Dana-Farber Affiliated Faculty Named as 2026 Top Doctors™ in Boston MagazineJanuary 27th, 2026
Low-Dose Aspirin Reduces Colon Cancer Risk in Patients with Lynch SyndromeJune 27th, 2025
Starch Supplement Reduces the Risk of Some Hereditary CancersJuly 26th, 2022